GO:0030554 | adenyl nucleotide binding | 24.55% (27/110) | 2.85 | 0.0 | 0.0 |
GO:0032559 | adenyl ribonucleotide binding | 24.55% (27/110) | 2.86 | 0.0 | 0.0 |
GO:0005524 | ATP binding | 24.55% (27/110) | 2.89 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 25.45% (28/110) | 2.66 | 0.0 | 0.0 |
GO:0008144 | drug binding | 24.55% (27/110) | 2.71 | 0.0 | 0.0 |
GO:0017076 | purine nucleotide binding | 25.45% (28/110) | 2.63 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 25.45% (28/110) | 2.64 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 25.45% (28/110) | 2.6 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 11.82% (13/110) | 4.51 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 25.45% (28/110) | 2.55 | 0.0 | 0.0 |
GO:1901265 | nucleoside phosphate binding | 27.27% (30/110) | 2.3 | 0.0 | 0.0 |
GO:0000166 | nucleotide binding | 27.27% (30/110) | 2.3 | 0.0 | 0.0 |
GO:0036094 | small molecule binding | 27.27% (30/110) | 2.21 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 22.73% (25/110) | 2.43 | 0.0 | 0.0 |
GO:0005488 | binding | 43.64% (48/110) | 1.42 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 5.45% (6/110) | 6.44 | 0.0 | 0.0 |
GO:0043168 | anion binding | 25.45% (28/110) | 2.14 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 31.82% (35/110) | 1.64 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 31.82% (35/110) | 1.64 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 24.55% (27/110) | 1.98 | 0.0 | 0.0 |
GO:0043167 | ion binding | 30.91% (34/110) | 1.62 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 26.36% (29/110) | 1.79 | 0.0 | 0.0 |
GO:0009987 | cellular process | 35.45% (39/110) | 1.39 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 12.73% (14/110) | 2.84 | 0.0 | 0.0 |
GO:0003774 | motor activity | 4.55% (5/110) | 5.18 | 0.0 | 2e-06 |
GO:0005515 | protein binding | 15.45% (17/110) | 2.08 | 0.0 | 4e-06 |
GO:0006260 | DNA replication | 4.55% (5/110) | 4.93 | 0.0 | 4e-06 |
GO:0071704 | organic substance metabolic process | 26.36% (29/110) | 1.39 | 1e-06 | 8e-06 |
GO:0003777 | microtubule motor activity | 3.64% (4/110) | 5.4 | 2e-06 | 1.3e-05 |
GO:0006928 | movement of cell or subcellular component | 3.64% (4/110) | 5.4 | 2e-06 | 1.3e-05 |
GO:0007018 | microtubule-based movement | 3.64% (4/110) | 5.4 | 2e-06 | 1.3e-05 |
GO:0090304 | nucleic acid metabolic process | 12.73% (14/110) | 2.23 | 2e-06 | 1.3e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 13.64% (15/110) | 2.09 | 2e-06 | 1.6e-05 |
GO:0008017 | microtubule binding | 3.64% (4/110) | 5.27 | 2e-06 | 1.8e-05 |
GO:0006807 | nitrogen compound metabolic process | 20.91% (23/110) | 1.51 | 4e-06 | 2.6e-05 |
GO:0008092 | cytoskeletal protein binding | 4.55% (5/110) | 4.23 | 6e-06 | 4.2e-05 |
GO:0046483 | heterocycle metabolic process | 13.64% (15/110) | 1.96 | 6e-06 | 4.3e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 13.64% (15/110) | 1.95 | 7e-06 | 4.5e-05 |
GO:0007017 | microtubule-based process | 3.64% (4/110) | 4.86 | 9e-06 | 5.6e-05 |
GO:1901360 | organic cyclic compound metabolic process | 13.64% (15/110) | 1.88 | 1.3e-05 | 7.8e-05 |
GO:0015631 | tubulin binding | 3.64% (4/110) | 4.61 | 1.8e-05 | 0.00011 |
GO:0003676 | nucleic acid binding | 13.64% (15/110) | 1.82 | 2.1e-05 | 0.000124 |
GO:0006996 | organelle organization | 4.55% (5/110) | 3.82 | 2.5e-05 | 0.000146 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 9.09% (10/110) | 2.35 | 2.7e-05 | 0.000151 |
GO:0051276 | chromosome organization | 3.64% (4/110) | 4.47 | 2.8e-05 | 0.000153 |
GO:0005694 | chromosome | 2.73% (3/110) | 5.44 | 3.4e-05 | 0.000177 |
GO:0016043 | cellular component organization | 6.36% (7/110) | 2.95 | 3.3e-05 | 0.000178 |
GO:0006468 | protein phosphorylation | 6.36% (7/110) | 2.81 | 6.3e-05 | 0.000317 |
GO:0071840 | cellular component organization or biogenesis | 6.36% (7/110) | 2.81 | 6.3e-05 | 0.000317 |
GO:0034641 | cellular nitrogen compound metabolic process | 13.64% (15/110) | 1.66 | 7.1e-05 | 0.000351 |
GO:0006796 | phosphate-containing compound metabolic process | 8.18% (9/110) | 2.32 | 8e-05 | 0.000377 |
GO:0006793 | phosphorus metabolic process | 8.18% (9/110) | 2.32 | 8e-05 | 0.000377 |
GO:0016310 | phosphorylation | 6.36% (7/110) | 2.73 | 8.7e-05 | 0.000403 |
GO:0004672 | protein kinase activity | 6.36% (7/110) | 2.68 | 0.000112 | 0.000509 |
GO:0044238 | primary metabolic process | 20.91% (23/110) | 1.16 | 0.000185 | 0.000827 |
GO:0003674 | molecular_function | 47.27% (52/110) | 0.62 | 0.000211 | 0.000928 |
GO:0017111 | nucleoside-triphosphatase activity | 6.36% (7/110) | 2.47 | 0.000265 | 0.001146 |
GO:0016462 | pyrophosphatase activity | 6.36% (7/110) | 2.44 | 0.000313 | 0.001328 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 6.36% (7/110) | 2.41 | 0.000353 | 0.001472 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 6.36% (7/110) | 2.38 | 0.000397 | 0.001628 |
GO:0008150 | biological_process | 37.27% (41/110) | 0.71 | 0.000406 | 0.001637 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 6.36% (7/110) | 2.37 | 0.000413 | 0.001638 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.82% (2/110) | 5.86 | 0.000437 | 0.001681 |
GO:0098687 | chromosomal region | 1.82% (2/110) | 5.86 | 0.000437 | 0.001681 |
GO:0016301 | kinase activity | 6.36% (7/110) | 2.35 | 0.000445 | 0.001686 |
GO:0008152 | metabolic process | 27.27% (30/110) | 0.85 | 0.00071 | 0.002645 |
GO:0006302 | double-strand break repair | 1.82% (2/110) | 5.54 | 0.000725 | 0.002661 |
GO:0006281 | DNA repair | 3.64% (4/110) | 3.24 | 0.000823 | 0.002977 |
GO:0034061 | DNA polymerase activity | 1.82% (2/110) | 5.27 | 0.001081 | 0.003853 |
GO:0140097 | catalytic activity, acting on DNA | 2.73% (3/110) | 3.86 | 0.001107 | 0.00389 |
GO:0006974 | cellular response to DNA damage stimulus | 3.64% (4/110) | 3.1 | 0.001189 | 0.004118 |
GO:0033554 | cellular response to stress | 3.64% (4/110) | 3.05 | 0.001362 | 0.004655 |
GO:0051716 | cellular response to stimulus | 3.64% (4/110) | 3.02 | 0.001456 | 0.004905 |
GO:0006464 | cellular protein modification process | 6.36% (7/110) | 2.02 | 0.001711 | 0.005612 |
GO:0036211 | protein modification process | 6.36% (7/110) | 2.02 | 0.001711 | 0.005612 |
GO:0009059 | macromolecule biosynthetic process | 7.27% (8/110) | 1.84 | 0.00183 | 0.005922 |
GO:0006950 | response to stress | 3.64% (4/110) | 2.77 | 0.002791 | 0.008917 |
GO:0030983 | mismatched DNA binding | 1.82% (2/110) | 4.54 | 0.00317 | 0.009748 |
GO:0050896 | response to stimulus | 3.64% (4/110) | 2.73 | 0.003101 | 0.009782 |
GO:0043412 | macromolecule modification | 6.36% (7/110) | 1.86 | 0.003155 | 0.009825 |
GO:0003690 | double-stranded DNA binding | 1.82% (2/110) | 4.4 | 0.003853 | 0.011559 |
GO:0006298 | mismatch repair | 1.82% (2/110) | 4.4 | 0.003853 | 0.011559 |
GO:0016740 | transferase activity | 10.0% (11/110) | 1.33 | 0.004235 | 0.012552 |
GO:0043226 | organelle | 7.27% (8/110) | 1.6 | 0.004853 | 0.014044 |
GO:0043229 | intracellular organelle | 7.27% (8/110) | 1.6 | 0.004853 | 0.014044 |
GO:0016779 | nucleotidyltransferase activity | 2.73% (3/110) | 3.08 | 0.005243 | 0.014998 |
GO:0140096 | catalytic activity, acting on a protein | 7.27% (8/110) | 1.51 | 0.007173 | 0.020281 |
GO:0045132 | meiotic chromosome segregation | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0003918 | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:1903046 | meiotic cell cycle process | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0003896 | DNA primase activity | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0000781 | chromosome, telomeric region | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:0000784 | nuclear chromosome, telomeric region | 0.91% (1/110) | 6.86 | 0.008624 | 0.02143 |
GO:1901576 | organic substance biosynthetic process | 8.18% (9/110) | 1.35 | 0.008938 | 0.021988 |
GO:0043565 | sequence-specific DNA binding | 1.82% (2/110) | 3.47 | 0.013908 | 0.033875 |
GO:0044267 | cellular protein metabolic process | 6.36% (7/110) | 1.46 | 0.014098 | 0.034 |
GO:0043047 | single-stranded telomeric DNA binding | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0005815 | microtubule organizing center | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0006269 | DNA replication, synthesis of RNA primer | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0031262 | Ndc80 complex | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0030036 | actin cytoskeleton organization | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0000228 | nuclear chromosome | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0098813 | nuclear chromosome segregation | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0017048 | Rho GTPase binding | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0030029 | actin filament-based process | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0098847 | sequence-specific single stranded DNA binding | 0.91% (1/110) | 5.86 | 0.017174 | 0.037389 |
GO:0006325 | chromatin organization | 1.82% (2/110) | 3.33 | 0.01657 | 0.039574 |
GO:0009058 | biosynthetic process | 8.18% (9/110) | 1.15 | 0.020217 | 0.042875 |
GO:0043232 | intracellular non-membrane-bounded organelle | 3.64% (4/110) | 1.95 | 0.020047 | 0.042883 |
GO:0043228 | non-membrane-bounded organelle | 3.64% (4/110) | 1.95 | 0.020047 | 0.042883 |
GO:0003916 | DNA topoisomerase activity | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0000775 | chromosome, centromeric region | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:1901071 | glucosamine-containing compound metabolic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0006265 | DNA topological change | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0042162 | telomeric DNA binding | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0060249 | anatomical structure homeostasis | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0004100 | chitin synthase activity | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0006022 | aminoglycan metabolic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0046349 | amino sugar biosynthetic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0032200 | telomere organization | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0006040 | amino sugar metabolic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:1901073 | glucosamine-containing compound biosynthetic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0006030 | chitin metabolic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0006023 | aminoglycan biosynthetic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0000723 | telomere maintenance | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0006031 | chitin biosynthetic process | 0.91% (1/110) | 5.27 | 0.025652 | 0.047446 |
GO:0044249 | cellular biosynthetic process | 7.27% (8/110) | 1.2 | 0.023167 | 0.048711 |